Article info
PostScript
Letter
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
- Correspondence to Dr Enrico N De Toni, Department of Internal Medicine II, University of Munich, Munich 81377, Germany; enrico.detoni{at}med.uni-muenchen.de
Citation
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
Publication history
- Received January 4, 2020
- Revised January 16, 2020
- Accepted February 1, 2020
- First published February 12, 2020.
Online issue publication
October 07, 2020
Article Versions
- Previous version (7 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.